We Need Subject Matter Expertise to Choose and Identify Causal Estimands: Comment on “Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event”-Reference-Cited by-同舟云学术

We Need Subject Matter Expertise to Choose and Identify Causal Estimands: Comment on “Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event”

Published:2023-04-03 Issue:2 Volume:15 Page:251-254
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Janvin Matias¹^ORCID,Young Jessica G.²³,Stensrud Mats J.¹

Affiliation:

1. Department of Mathematics, École Polytechnique Fédérale de Lausanne, Switzerland

2. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA

3. Department of Epidemiology, Harvard T. H. Chan School of Public Health, CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2022.2108138

Reference26 articles.

1. Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials

2. "Imagine a Can Opener"--The Magic of Principal Stratum Analysis

3. Defining causal mediation with a longitudinal mediator and a survival outcome

4. EMA (2020), “ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” Technical Report.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles for Defining Estimands in Clinical Trials—A Proposal;Pharmaceutical Statistics;2024-08-13

2. Story-led Causal Inference;Epidemiology;2024-04-18